JP2009543825A5 - - Google Patents

Download PDF

Info

Publication number
JP2009543825A5
JP2009543825A5 JP2009519861A JP2009519861A JP2009543825A5 JP 2009543825 A5 JP2009543825 A5 JP 2009543825A5 JP 2009519861 A JP2009519861 A JP 2009519861A JP 2009519861 A JP2009519861 A JP 2009519861A JP 2009543825 A5 JP2009543825 A5 JP 2009543825A5
Authority
JP
Japan
Prior art keywords
treatment
drug
abuse
anxiety
stress
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009519861A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009543825A (ja
JP5269784B2 (ja
Filing date
Publication date
Priority claimed from DE102006033114A external-priority patent/DE102006033114A1/de
Application filed filed Critical
Publication of JP2009543825A publication Critical patent/JP2009543825A/ja
Publication of JP2009543825A5 publication Critical patent/JP2009543825A5/ja
Application granted granted Critical
Publication of JP5269784B2 publication Critical patent/JP5269784B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009519861A 2006-07-18 2007-07-17 スピロ環状アザインドール誘導体 Expired - Fee Related JP5269784B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006033114A DE102006033114A1 (de) 2006-07-18 2006-07-18 Spirocyclische Azaindol-Derivate
DE102006033114.1 2006-07-18
PCT/EP2007/006326 WO2008009416A1 (de) 2006-07-18 2007-07-17 Spirocyclische azaindol-derivate

Publications (3)

Publication Number Publication Date
JP2009543825A JP2009543825A (ja) 2009-12-10
JP2009543825A5 true JP2009543825A5 (cg-RX-API-DMAC10.html) 2013-04-11
JP5269784B2 JP5269784B2 (ja) 2013-08-21

Family

ID=38704887

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009519861A Expired - Fee Related JP5269784B2 (ja) 2006-07-18 2007-07-17 スピロ環状アザインドール誘導体

Country Status (21)

Country Link
US (1) US8399503B2 (cg-RX-API-DMAC10.html)
EP (1) EP2041142B1 (cg-RX-API-DMAC10.html)
JP (1) JP5269784B2 (cg-RX-API-DMAC10.html)
KR (1) KR101421034B1 (cg-RX-API-DMAC10.html)
CN (1) CN101490055B (cg-RX-API-DMAC10.html)
AR (1) AR062079A1 (cg-RX-API-DMAC10.html)
AU (1) AU2007276414B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0714650A2 (cg-RX-API-DMAC10.html)
CA (1) CA2658379C (cg-RX-API-DMAC10.html)
CL (1) CL2007001917A1 (cg-RX-API-DMAC10.html)
DE (1) DE102006033114A1 (cg-RX-API-DMAC10.html)
ES (1) ES2434114T3 (cg-RX-API-DMAC10.html)
IL (1) IL196525A (cg-RX-API-DMAC10.html)
MX (1) MX2009000670A (cg-RX-API-DMAC10.html)
NO (1) NO342282B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ573688A (cg-RX-API-DMAC10.html)
PE (1) PE20080277A1 (cg-RX-API-DMAC10.html)
PL (1) PL2041142T3 (cg-RX-API-DMAC10.html)
RU (1) RU2468028C2 (cg-RX-API-DMAC10.html)
WO (1) WO2008009416A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200901128B (cg-RX-API-DMAC10.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005016460A1 (de) * 2005-04-11 2006-10-19 Grünenthal GmbH Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
DE102006033114A1 (de) 2006-07-18 2008-01-24 Grünenthal GmbH Spirocyclische Azaindol-Derivate
CL2009000731A1 (es) 2008-03-27 2009-05-15 Gruenenthal Gmbh Compuestos derivados de ciclohexano espirociclicos sustituidos, composicion farmaceutica que contiene a dicho compuesto y su uso como moduladores del receptor de opioides µ y el receptor orl-1 para tratar el dolor, ansiedad, depresion, epilepsia, alzheimer, abuso de alcohol, hipertension, anorexia, obesidad y diarrea.
EP2260022B1 (de) 2008-03-27 2017-01-04 Grünenthal GmbH Substituierte cyclohexyldiamine
AU2009228637B2 (en) * 2008-03-27 2013-12-19 Grunenthal Gmbh (Hetero-)aryl cyclohexane derivatives
HRP20140650T1 (hr) 2008-03-27 2014-09-26 Grünenthal GmbH Hidroksimetilcikloheksilamini
JP5542119B2 (ja) * 2008-03-27 2014-07-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング スピロ(5.5)ウンデカン誘導体
KR20120075500A (ko) 2008-03-27 2012-07-06 그뤼넨탈 게엠베하 치환된 4-아미노사이클로헥산 유도체
WO2011153359A1 (en) 2010-06-04 2011-12-08 Albany Molecular Research, Inc. Glycine transporter-1 inhibitors, methods of making them, and uses thereof
TWI582092B (zh) 2010-07-28 2017-05-11 歌林達股份有限公司 順式-四氫-螺旋(環己烷-1,1’-吡啶[3,4-b]吲哚)-4-胺-衍生物
PL2649044T3 (pl) 2010-12-08 2018-02-28 Grünenthal GmbH Sposób syntezy podstawionych pochodnych aminocykloheksanonu
WO2015138791A1 (en) * 2014-03-12 2015-09-17 The Trustees Of Columbia University In The City Of New York A new class of mu-opioid receptor agonists
ES2686326T3 (es) 2014-07-15 2018-10-17 Grünenthal GmbH Derivados de azaspiro(4,5)decano sustituidos
TW201607923A (zh) 2014-07-15 2016-03-01 歌林達有限公司 被取代之氮螺環(4.5)癸烷衍生物
AU2016323977B9 (en) 2015-09-16 2021-03-04 The Trustees Of Columbia University In The City Of New York Carboxylic diarylthiazepineamines as mu-opioid receptor agonists
CN117447384B (zh) * 2023-10-24 2024-12-27 四川大学 一种螺杂环芳基类化合物及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065573A (en) 1976-06-03 1977-12-27 The Upjohn Company 4-Amino-4-phenylcyclohexanone ketal compositions and process of use
EP0738717A1 (en) 1990-10-09 1996-10-23 Neurogen Corporation Certain substituted pyrimidines as intermediates for production of cycloalkyl and azacycloalkyl pyrrolopyrimidines
CA2356269A1 (en) * 1998-12-24 2000-07-06 Yoshihisa Akiyama Pain control agent
GB9918965D0 (en) 1999-08-11 1999-10-13 Cerebrus Ltd Chemical compounds xxi
HUP0300413A2 (hu) * 2000-04-10 2003-06-28 Pfizer Products Inc. Amidcsoportot viselő benzolgyűrűs csoporttal helyettesített piperidint tartalmazó és rokonszerkezetű vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
DE10123163A1 (de) 2001-05-09 2003-01-16 Gruenenthal Gmbh Substituierte Cyclohexan-1,4-diaminderivate
RU2216737C1 (ru) * 2002-03-19 2003-11-20 Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова Способ оценки течения хронического воспалительного процесса в бронхолегочной системе больного муковисцидозом
DE10252667A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
WO2004113300A1 (ja) * 2003-06-23 2004-12-29 Ono Pharmaceutical Co., Ltd. 新規三環性複素環化合物
DE10360792A1 (de) * 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE10360793A1 (de) 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102004039382A1 (de) 2004-08-13 2006-02-23 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
US7659264B2 (en) * 2004-10-07 2010-02-09 Merck Sharp & Dohme Corp. CGRP receptor antagonists
EP1829874B1 (en) * 2004-12-22 2014-02-12 Ono Pharmaceutical Co., Ltd. Tricyclic compound and use thereof
DE102005016460A1 (de) 2005-04-11 2006-10-19 Grünenthal GmbH Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
DE102006019597A1 (de) 2006-04-27 2007-10-31 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102006033114A1 (de) 2006-07-18 2008-01-24 Grünenthal GmbH Spirocyclische Azaindol-Derivate
DE102007009319A1 (de) 2007-02-22 2008-08-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102007009235A1 (de) 2007-02-22 2008-09-18 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
CL2009000731A1 (es) 2008-03-27 2009-05-15 Gruenenthal Gmbh Compuestos derivados de ciclohexano espirociclicos sustituidos, composicion farmaceutica que contiene a dicho compuesto y su uso como moduladores del receptor de opioides µ y el receptor orl-1 para tratar el dolor, ansiedad, depresion, epilepsia, alzheimer, abuso de alcohol, hipertension, anorexia, obesidad y diarrea.

Similar Documents

Publication Publication Date Title
JP2011517670A5 (cg-RX-API-DMAC10.html)
JP2011515430A5 (cg-RX-API-DMAC10.html)
JP2011512374A5 (cg-RX-API-DMAC10.html)
JP7795482B2 (ja) 5-メトキシ-n,n-ジメチルトリプタミンの安息香酸塩を含む組成物
WO2023111544A2 (en) Benzoate salt of 5-methoxy-n,n-dimethyltryptamine
JP2011515429A5 (cg-RX-API-DMAC10.html)
WO2014085362A1 (en) Methods for the treatment of parkinson's disease psychosis using pimavanserin
RU2010126622A (ru) Конденсированные с арилом и гетероарилом имидазо[1, 5-а]пиразины в качестве ингибиторов фосфодиэстеразы 10
CN101203216A (zh) 二氢苯并呋喃衍生物及其用途
BR112017017349B1 (pt) Composto e seu uso, composição, processo para preparar um composto e processo para separar um composto
WO2004014428A1 (ja) 腸疾患および内臓痛の治療薬
JP2012508275A5 (cg-RX-API-DMAC10.html)
UY27735A1 (es) Hidrato de un antagonista de receptores muscarínicos.
JP2015521643A5 (cg-RX-API-DMAC10.html)
TW200613255A (en) Therapeutic diphenyl ether ligands
HRP20120017T1 (hr) Derivati spiro(5.5)undekana
JP2022506113A5 (cg-RX-API-DMAC10.html)
JP2008540592A5 (ja) 置換されたスピロ化合物及び鎮痛剤の製造へのその使用
US20260041667A1 (en) Prescription digital therapeutics
Davies et al. A novel series of benzimidazole NR2B-selective NMDA receptor antagonists
JP2008538366A5 (cg-RX-API-DMAC10.html)
AU2022405025A1 (en) Benzofuran salt morphic forms and mixtures for the treatment of mental disorders or mental enhancement
CN109890798A (zh) 用于治疗cns病症的羟基去甲氯胺酮衍生物
JP2007536317A5 (cg-RX-API-DMAC10.html)
JP2006502171A5 (cg-RX-API-DMAC10.html)